Alecta Tjanstepension Omsesidigt lowered its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 27.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 722,800 shares of the company's stock after selling 277,200 shares during the quarter. Alecta Tjanstepension Omsesidigt owned 0.34% of Bath & Body Works worth $21,908,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also made changes to their positions in the company. Golden State Wealth Management LLC raised its stake in Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares during the last quarter. UMB Bank n.a. raised its holdings in Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after buying an additional 596 shares during the period. Ancora Advisors LLC acquired a new position in shares of Bath & Body Works during the fourth quarter worth about $67,000. TD Private Client Wealth LLC boosted its holdings in Bath & Body Works by 34.9% in the 4th quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock worth $89,000 after acquiring an additional 593 shares during the period. Finally, Quarry LP acquired a new position in Bath & Body Works in the 4th quarter worth $122,000. 95.14% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on BBWI shares. The Goldman Sachs Group decreased their target price on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Raymond James Financial reduced their price objective on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research report on Thursday, April 17th. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Barclays reduced their price objective on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a report on Friday, May 30th. Finally, UBS Group boosted their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.00.
View Our Latest Report on Bath & Body Works
Bath & Body Works Stock Up 2.4%
NYSE BBWI traded up $0.76 on Tuesday, reaching $33.12. The company had a trading volume of 5,056,454 shares, compared to its average volume of 5,268,174. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The stock's 50 day moving average is $30.16 and its 200-day moving average is $32.21. The stock has a market cap of $7.01 billion, a price-to-earnings ratio of 8.83, a PEG ratio of 1.09 and a beta of 1.72.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. Bath & Body Works's revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.38 earnings per share. As a group, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were given a dividend of $0.20 per share. The ex-dividend date was Friday, June 6th. This represents a $0.80 annualized dividend and a yield of 2.42%. Bath & Body Works's dividend payout ratio (DPR) is presently 21.33%.
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.